ASPEN AEROGELS INC - COMMON STOCK (ASPN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
ASPN on NYSE
Shares outstanding
81,738,225
Price per share
$2.83
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
71,405,754
Total reported value
$497,064,440
% of total 13F portfolios
0%
Share change
-362,195
Value change
-$253,889
Number of holders
201
Price from insider filings
$2.83
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ASPEN AEROGELS INC - COMMON STOCK (ASPN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OAKTOP CAPITAL MANAGEMENT II, L.P. 5.4% $23,994,106 4,394,525 Oaktop Capital Management II, L.P. 31 Mar 2025
FMR LLC 1.5% $6,694,361 1,226,073 FMR LLC 31 Dec 2024

As of 30 Sep 2025, 201 institutional investors reported holding 71,405,754 shares of ASPEN AEROGELS INC - COMMON STOCK (ASPN). This represents 87% of the company’s total 81,738,225 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ASPEN AEROGELS INC - COMMON STOCK (ASPN) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
KIM, LLC 15% 12,280,426 0% 9.6% $85,471,765
BlackRock, Inc. 6.1% 4,977,558 +0.01% 0% $34,643,803
VANGUARD GROUP INC 5.5% 4,510,370 +0.51% 0% $31,392,177
OAKTOP CAPITAL MANAGEMENT II, L.P. 5.4% 4,394,525 0% 2.8% $30,585,894
NEEDHAM INVESTMENT MANAGEMENT LLC 4.2% 3,439,700 +14% 1.7% $23,940,312
George Kaiser Family Foundation 3.9% 3,167,322 0% 3.1% $22,044,561
DIMENSIONAL FUND ADVISORS LP 2.8% 2,252,013 -8% 0% $15,674,611
STATE STREET CORP 2.4% 1,944,636 +1.2% 0% $13,534,667
Telemark Asset Management, LLC 2.2% 1,792,424 0% 1.2% $12,475,271
GAGNON SECURITIES LLC 2.1% 1,754,833 -7.6% 2.5% $12,213,638
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,584,871 +0.13% 0% $11,032,256
AWM Investment Company, Inc. 1.9% 1,555,477 +8.4% 1% $10,826,120
MILLENNIUM MANAGEMENT LLC 1.8% 1,447,517 +60% 0.01% $10,074,718
GOLDMAN SACHS GROUP INC 1.7% 1,419,804 -36% 0% $9,881,836
RICE HALL JAMES & ASSOCIATES, LLC 1.7% 1,407,726 -8.9% 0.53% $9,797,769
JPMORGAN CHASE & CO 1.7% 1,349,749 +8.3% 0% $9,394,254
Invesco Ltd. 1.5% 1,222,376 +47% 0% $8,507,737
CITADEL ADVISORS LLC 1.4% 1,114,590 +584% 0.01% $7,757,546
Penn Capital Management Company, LLC 1.3% 1,036,995 +39% 0.56% $7,225,251
BANK OF AMERICA CORP /DE/ 1% 814,849 -0.41% 0% $5,671,349
TWO SIGMA INVESTMENTS, LP 0.99% 811,528 +5.2% 0.01% $5,648,235
NEW YORK STATE COMMON RETIREMENT FUND 0.88% 720,024 +46% 0.01% $5,011,367
MORGAN STANLEY 0.85% 694,488 -1.6% 0% $4,833,641
BNP PARIBAS FINANCIAL MARKETS 0.85% 692,148 0% 0% $4,817,350
NORTHERN TRUST CORP 0.75% 613,598 +1.6% 0% $4,270,641

Institutional Holders of ASPEN AEROGELS INC - COMMON STOCK (ASPN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 361,310 $1,022,216 -$105,970 $2.83 4
2025 Q3 71,405,754 $497,064,440 -$253,889 $6.96 201
2025 Q2 71,504,120 $423,792,194 -$835,712 $5.92 181
2025 Q1 71,206,827 $455,066,397 -$45,808,861 $6.39 217
2024 Q4 73,001,355 $867,778,873 -$105,657,383 $11.88 228
2024 Q3 69,401,034 $1,921,862,940 -$22,829,124 $27.69 238
2024 Q2 70,532,807 $1,682,097,439 -$78,212,843 $23.85 216
2024 Q1 74,247,101 $1,306,720,369 -$2,830,981 $17.60 162
2023 Q4 74,870,231 $1,181,354,395 +$136,924,909 $15.78 166
2023 Q3 67,761,200 $582,778,595 +$28,805,579 $8.60 157
2023 Q2 66,512,915 $524,617,340 -$10,871,982 $7.89 158
2023 Q1 67,189,026 $498,597,203 -$26,918,463 $7.45 155
2022 Q4 67,314,459 $793,543,467 +$354,475,790 $11.79 160
2022 Q3 37,314,044 $344,117,328 +$407,623 $9.22 129
2022 Q2 37,073,093 $366,274,596 -$154,400,198 $9.88 140
2022 Q1 31,696,973 $1,092,653,529 +$98,738,568 $34.48 139
2021 Q4 28,529,908 $1,420,617,488 +$23,952,968 $49.79 156
2021 Q3 27,563,849 $1,268,080,803 -$1,101,618 $46.01 127
2021 Q2 28,413,761 $849,796,727 +$128,951,542 $29.92 113
2021 Q1 23,708,215 $482,202,043 +$36,805,215 $20.34 83
2020 Q4 21,889,127 $365,972,946 +$23,787,605 $16.69 75
2020 Q3 19,785,359 $216,652,920 +$7,771,398 $10.95 70
2020 Q2 19,371,151 $127,452,961 +$4,920,549 $6.58 66
2020 Q1 18,698,262 $114,805,860 +$12,104,709 $6.14 60
2019 Q4 16,704,164 $129,617,086 +$3,000,579 $7.76 48
2019 Q3 16,421,121 $97,214,829 +$2,077,389 $5.92 40
2019 Q2 16,067,293 $114,557,998 -$775,410 $7.13 33
2019 Q1 16,264,254 $41,473,357 +$462,305 $2.55 34
2018 Q4 16,268,661 $34,654,000 -$2,674,185 $2.13 34
2018 Q3 16,533,099 $75,556,000 -$838,545 $4.57 43
2018 Q2 16,717,271 $81,915,000 -$334,389 $4.90 45
2018 Q1 16,857,273 $72,118,000 +$391,285 $4.27 50
2017 Q4 16,760,070 $81,789,000 -$2,427,044 $4.88 48
2017 Q3 17,580,213 $76,466,000 +$30,156 $4.35 50
2017 Q2 17,552,005 $78,018,000 +$74,932 $4.45 44
2017 Q1 17,469,551 $72,498,000 +$5,754,386 $4.15 42
2016 Q4 17,165,402 $70,900,000 -$7,510,166 $4.13 51
2016 Q3 17,557,373 $104,642,000 +$709,552 $5.96 52
2016 Q2 17,731,033 $88,125,000 -$744,179 $4.97 57
2016 Q1 17,935,512 $80,706,000 -$4,112,514 $4.50 51
2015 Q4 18,520,450 $112,421,000 +$1,185,718 $6.07 45
2015 Q3 18,246,842 $136,824,338 -$791,293 $7.50 52
2015 Q2 18,369,731 $121,586,996 -$3,205,170 $6.62 41
2015 Q1 18,811,648 $137,040,953 -$3,131,332 $7.28 40
2014 Q4 19,238,899 $153,400,249 -$2,659,830 $7.98 35
2014 Q3 19,471,422 $196,270,000 +$65,390 $10.08 41
2014 Q2 19,382,265 $214,120,250 +$214,120,250 $11.05 28